nach oben

Acta Diabetologica

Erschienen in:

29.05.2017 | Original Article

The affective and somatic side of depression: subtypes of depressive symptoms show diametrically opposed associations with glycemic control in people with type 1 diabetes

verfasst von: Dominic Ehrmann, Andreas Schmitt, André Reimer, Thomas Haak, Bernhard Kulzer, Norbert Hermanns

Erschienen in: Acta Diabetologica | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Aims

While depression has been linked to serious adverse outcomes in diabetes, associations with glycemic control are not conclusive. Inconsistencies could be due to the complex symptomatology of depression. Aim of this study was to analyze the associations of depressive subtypes with glycemic control in people with type 1 and type 2 diabetes.

Methods

Patients completed the Center for Epidemiological Studies-Depression scale which comprises affective, somatic, and anhedonic symptoms. These subtypes were analyzed in a joint linear regression analysis with glycemic control as a dependent variable. Subtype scores were calculated as mean item scores. Separate analyses for people with type 1 and type 2 diabetes were conducted. All analyses were controlled for demographic and medical confounders.

Results

The sample comprised 604 patients with type 1 and 382 patients with type 2 diabetes. In people with type 1 diabetes, the somatic and affective subtype showed diametrically opposed associations with glycemic control (somatic: β =+0.23, p < .05; affective: β = −0.23, p < .05). Anhedonia was not significantly associated with glycemic control. In people with type 2 diabetes, none of the depressive subtypes was significantly associated with glycemic control.

Conclusions

For people with type 1 diabetes, the distinction of subtypes offered a detailed picture of the associations of depressive symptoms with glycemic control. However, due to the cross-sectional design, inferences about the direction of these associations cannot be made. In clinical practice, instead of focusing on overall depression, healthcare providers should examine the nature of depressive symptoms and how they might be related to having diabetes.

Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006) The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med 23(11):1165–1173CrossRefPubMed

Barnard KD, Skinner TC, Peveler R (2006) The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review. Diabet Med 23(4):445–448CrossRefPubMed

Katon W, Fan MY, Unutzer J, Taylor J, Pincus H, Schoenbaum M (2008) Depression and diabetes: a potentially lethal combination. J Gen Internal Med 23(10):1571–1575CrossRef

Schram MT, Baan CA, Pouwer F (2009) Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr Diabetes Rev 5(2):112–119CrossRefPubMedPubMedCentral

Gonzalez JS, Safren SA, Delahanty LM et al (2008) Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes. Diabet Med 25(9):1102–1107CrossRefPubMedPubMedCentral

Black SA, Markides KS, Ray LA (2003) Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 26(10):2822–2828CrossRefPubMed

van Dooren FE, Nefs G, Schram MT, Verhey FR, Denollet J, Pouwer F (2013) Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis. PLoS ONE 8(3):e57058CrossRefPubMedPubMedCentral

Lustman PJ, Anderson RJ, Freedland KE, De Groot M, Carney RM, Clouse RE (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23(7):934–942CrossRefPubMed

Aikens JE, Perkins DW, Lipton B, Piette JD (2009) Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes. Diabetes Care 32(7):1177–1181CrossRefPubMedPubMedCentral

10.

Fisher L, Mullan JT, Arean P, Glasgow RE, Hessler D, Masharani U (2010) Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care 33(1):23–28CrossRefPubMed

11.

Asuzu CC, Walker RJ, Williams JS, Egede LE (2016) Pathways for the relationship between diabetes distress, depression, fatalism and glycemic control in adults with type 2 diabetes. J Diabetes Complicat 31(1):169–174CrossRefPubMed

12.

McGrady ME, Laffel L, Drotar D, Repaske D, Hood KK (2009) Depressive symptoms and glycemic control in adolescents with type 1 diabetes mediational role of blood glucose monitoring. Diabetes Care 32(5):804–806CrossRefPubMedPubMedCentral

13.

van Bastelaar KM, Pouwer F, Geelhoed-Duijvestijn PH et al (2010) Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in Type 1 and Type 2 diabetes. Diabet Med 27(7):798–803CrossRefPubMed

14.

Schmitt A, Reimer A, Kulzer B, Haak T, Gahr A, Hermanns N (2015) Negative association between depression and diabetes control only when accompanied by diabetes-specific distress. J Behav Med 38(3):556–564CrossRefPubMed

15.

Baumeister H, Hutter N, Bengel J (2014) Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review. Diabet Med 31(7):773–786CrossRefPubMed

16.

Petrak F, Herpertz S, Albus C et al (2015) Cognitive behavioral therapy versus sertraline in patients with depression and poorly controlled diabetes: the diabetes and depression (DAD) study: a randomized controlled multicenter trial. Diabetes Care 38(5):767–775CrossRefPubMed

17.

Georgiades A, Zucker N, Friedman KE et al (2007) Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosom Med 69(3):235–241CrossRefPubMed

18.

van der Feltz-Cornelis CM, Nuyen J, Stoop C et al (2010) Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry 32(4):380–395CrossRefPubMed

19.

Hermanns N, Schmitt A, Gahr A et al (2015) The effect of a Diabetes-Specific Cognitive Behavioral Treatment Program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trial. Diabetes Care 38(4):551–560PubMed

20.

Lux V, Kendler KS (2010) Deconstructing major depression: a validation study of the DSM-IV symptomatic criteria. Psychol Med 40(10):1679–1690CrossRefPubMedPubMedCentral

21.

de Jonge P (2011) Depression deconstruction lessons from psychosomatic research. J Psychosom Res 71(2):59–60CrossRefPubMed

22.

Nefs G, Pop VJM, Denollet J, Fo Pouwer (2015) Depressive symptom clusters differentially predict cardiovascular hospitalization in people with type 2 diabetes. Psychosomatics 56(6):662–673CrossRefPubMed

23.

Stewart JC, Zielke DJ, Hawkins MAW et al (2012) Depressive symptom clusters and 5-year incidence of coronary artery calcification: the CARDIA study. Circulation 126:410–417CrossRefPubMedPubMedCentral

24.

Bot M, Pouwer F, de Jonge P, Tack CJ, Geelhoed-Duijvestijn PH, Snoek FJ (2013) Differential associations between depressive symptoms and glycaemic control in outpatients with diabetes. Diabet Med 30(3):e115–e122CrossRefPubMed

25.

Baechle C, Lange K, Stahl-Pehe A et al (2015) Associations between HbA1c and depressive symptoms in young adults with early-onset type 1 diabetes. Psychoneuroendocrinology 55:48–58CrossRef

26.

van Steenbergen-Weijenburg KM, de Vroege L, Ploeger RR et al (2010) Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Serv Res 10:235CrossRefPubMedPubMedCentral

27.

Manea L, Gilbody S, McMillan D (2015) A diagnostic meta-analysis of the Patient Health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiatry 37(1):67–75CrossRefPubMed

28.

Radloff LS (1977) The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas 3:385–401CrossRef

29.

Shafer AB (2006) Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol 62(1):123–146CrossRefPubMed

30.

Ehrmann D, Bergis-Jurgan N, Haak T, Kulzer B, Hermanns N (2016) Comparison of the efficacy of a diabetes education programme for type 1 diabetes (PRIMAS) in a randomised controlled trial setting and the effectiveness in a routine care setting: results of a comparative effectiveness study. PLoS ONE 11(1):e0147581CrossRefPubMedPubMedCentral

31.

Hermanns N, Kulzer B, Maier B, Mahr M, Haak T (2012) The effect of an education programme (MEDIAS 2 ICT) involving intensive insulin treatment for people with type 2 diabetes. Patient Educ Couns 86(2):226–232CrossRefPubMed

32.

Polonsky WH, Anderson BJ, Lohrer PA et al (1995) Assessment of diabetes-related distress. Diabetes Care 18(6):754–760CrossRefPubMed

33.

Melin EO, Thunander M, Svensson R, Landin-Olsson M, Thulesius HO (2013) Depression, obesity, and smoking were independently associated with inadequate glycemic control in patients with type 1 diabetes. Eur J Endocrinol 168(6):861–869CrossRefPubMed

34.

Reutrakul S, Thakkinstian A, Anothaisintawee T et al (2016) Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis. Sleep Med 23:26–45CrossRefPubMed

35.

Denic-Roberts H, Costacou T, Orchard TJ (2016) Subjective sleep disturbances and glycemic control in adults with long-standing type 1 diabetes: the Pittsburgh’s epidemiology of diabetes complications study. Diabetes Res Clin Pract 119:1–12CrossRefPubMed

36.

Gonzalez JS, Kane NS, Binko DH, Shapira A, Hoogendoorn CJ (2016) Tangled up in blue: unraveling the links between emotional distress and treatment adherence in type 2 diabetes. Diabetes Care. doi:10.2337/dc16-1657

37.

Stewart JC, Rand KL, Muldoon MF, Kamarck TW (2009) A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun 23(7):936–944CrossRefPubMedPubMedCentral

38.

King DE, Mainous AG, Buchanan TA, Pearson WS (2003) C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 26(5):1535–1539CrossRefPubMed

39.

De Groot M, Jacobson AM, Samson JA, Welch G (1999) Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. J Psychosom Res 46(5):425–435CrossRefPubMed

40.

Surwit RS, van Tilburg MAL, Parekh PI, Lane JD, Feinglos MN (2005) Treatment regimen determines the relationship between depression and glycemic control. Diabetes Res Clin Pract 69(1):78–80CrossRefPubMed

41.

Nefs G, Pouwer F, Denollet J, Kramer H, Wijnands-van Gent CJ, Pop VJ (2012) Suboptimal glycemic control in type 2 diabetes: a key role for anhedonia? J Psychiatr Res 46(4):549–554CrossRefPubMed

42.

Hawkins MAW, Callahan CM, Stump TE, Stewart JC (2014) Depressive symptom clusters as predictors of incident coronary artery disease events: a 15-year prospective study of older adults. Psychosom Med 76(1):38CrossRefPubMed

Titel: The affective and somatic side of depression: subtypes of depressive symptoms show diametrically opposed associations with glycemic control in people with type 1 diabetes
verfasst von: Dominic Ehrmann
Andreas Schmitt
André Reimer
Thomas Haak
Bernhard Kulzer
Norbert Hermanns
Publikationsdatum: 29.05.2017
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 8/2017
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-017-1006-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The affective and somatic side of depression: subtypes of depressive symptoms show diametrically opposed associations with glycemic control in people with type 1 diabetes

Abstract

Aims

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Aims

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2017

Lifestyle-tailored interventions for South Asians with type 2 diabetes living in high-income countries: a systematic review

Ischemic index changes in diabetic retinopathy after intravitreal dexamethasone implant using ultra-widefield fluorescein angiography: a pilot study

Role of the PKCβII/JNK signaling pathway in acute glucose fluctuation-induced apoptosis of rat vascular endothelial cells

Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity

Bilateral chorea–ballism and diabetic ketoacidosis as the initial presentation of a case with maternally inherited diabetes and deafness

Tailoring pharmacotherapy to specific eating behaviours in obesity: Can recommendations for personalised therapy be made from the current data?

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin